James P. Nygaard, Jr. has served as Executive Vice President and Chief Financial Officer of Core Scientific since March 17, 2025. He brings over 30 years of investment banking and corporate finance experience, having completed numerous strategic transactions and financings across diverse industry sectors.
Prior to joining Core Scientific, Nygaard was a Managing Director at XMS Capital Partners, LLC from 2008, where he led the firm's M&A execution activities and strategic financings, and chaired the firm's Fairness Committee. He previously served as Chief Financial Officer of Power & Digital Infrastructure Acquisition Corp. (XPDI), the predecessor of Core Scientific through merger, from January 2021 to January 2022. Earlier in his career, from 1995 to 2007, he held various roles in corporate finance and M&A within the Investment Banking Division of Morgan Stanley & Co. LLC.
Nygaard graduated summa cum laude from the University of Illinois at Urbana-Champaign with a Bachelor of Arts in Economics, where he was his department's valedictorian and received Bronze Tablet Honors, the university's highest academic distinction.
Biography extracted from Core Scientific DEF 14A filed 2026-03-31 View cached copy (2026-08-31)Live source ↗
Photo: www.corescientific.com (Core Scientific official site) · retrieved 2026-08-31 · cached copy · match confidence high
Roles
Contiguous filings for the same role are collapsed into a single tenure span. Click a row to see the underlying filings.
| Company | Role | Tenure | Filings |
|---|---|---|---|
| Core Scientific | EVP, Chief Financial Officer | 2026-05 → present (4mo) | 1 |
Compensation
| Year | Role as filed | Salary | Stock awards | Incentive | Other | Total | Source |
|---|---|---|---|---|---|---|---|
| 2025 | Executive Vice President, Chief Financial Officer | $450.0K | $8.00M | $1.20M | $30.4K | $9.68M | View cached copy (2026-08-31)Live source ↗ |
As reported in the company's DEF 14A Summary Compensation Table (SEC Reg S-K Item 402(c)). Stock and option awards are grant-date fair values — what the award was worth on the day it was granted, not cash received and not what it is worth now. Every row here reconciles: its columns add up to the total the filing printed.
Insider transactions
Totals for this person
| Bucket | Invested (shares) | Invested (USD) | Divested (shares) | Divested (USD) | Net direction | Txns | Invested @ last price | Divested @ last price |
|---|---|---|---|---|---|---|---|---|
| All time | 120,074 | $0 | - | $0 | Flat | 1 | $2.15M | $0 |
| 2026 | 120,074 | $0 | - | $0 | Flat | 1 | $2.15M | $0 |
| 2026-Q2 | 120,074 | $0 | - | $0 | Flat | 1 | $2.15M | $0 |
Invested = shares acquired (buys, grants, option exercises) — insider adding to the position. Divested = shares reduced (sells, dispositions, tax-withholding) — cash flowing TO the insider. Net direction shows which side wins on dollar terms in each bucket. % of holder's stake not yet computed (pending Form 3/4 holdings ingest). See methodology. The two @ last price columns restate the same share counts at the most recent share price we read (close of 2026-09-04); they are a valuation, not a cash flow, and they move every day the market does.
All transactions
| Date | Company | Kind | Shares | Amount (USD) | Value @ last price |
|---|---|---|---|---|---|
| 2026-05-20 | Core Scientific | Grant / award / vesting | 120,074 | - | $2.15M |